Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Thumbnail
Fulltext:
193607.pdf
Size:
1012.Kb
Format:
PDF
Description:
publisher's version
Download
Publication year
2018
Author(s)
Boer, S.M. de
Powell, M.E.
Mileshkin, L.
Katsaros, D.
Bessette, P.
Haie-Meder, C.
Ottevanger, P.B.
Ledermann, J.A.
Khaw, P.
Colombo, A.
Fyles, A.
Baron, M.H.
Jurgenliemk-Schulz, I.M.
Kitchener, H.C.
Nijman, H.W.
Wilson, G.
Brooks, S.
Carinelli, S.
Provencher, D.M.
Hanzen, C.
Lutgens, L.C.
Smit, V.T.
Singh, N.
Do, V.
D'Amico, R.
Nout, R.A.
Feeney, A.
Verhoeven-Adema, K.W.
Snyers, A.
Putter, H.
Creutzberg, C.L.
Source
Lancet Oncology, 19, 3, (2018), pp. 295-309
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/193607   https://hdl.handle.net/2066/193607
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.